Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$6.57 - $12.0 $16,398 - $29,952
-2,496 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$13.65 - $22.4 $34,862 - $57,209
-2,554 Reduced 50.57%
2,496 $51,000
Q2 2021

Aug 16, 2021

BUY
$20.96 - $42.81 $105,848 - $216,190
5,050 New
5,050 $106,000

Others Institutions Holding PRTG

About PORTAGE BIOTECH INC.


  • Ticker PRTG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,943,700
  • Market Cap $117M
  • Description
  • Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...
More about PRTG
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.